• 011-26907444
  • raghava@iiitd.ac.in

Welcome to Peptide Card of AntiTbPdb

This page displays user query in tabular form.

FWGLKGLKGPGKFSKKL details
Primary information
ID antitb_1193,
Name25019413
N-Terminal modificationPin2 [17]
C-Terminal ModificationFWGLKGLKGPGKFSKKL
Chemical ModificationFree
Linear/CyclicFree
LengthNone
ChiralityLinear
Nature17
SourceL
OriginCationic
SpeciesSynthetic
StrainShort variant of Pin3
Inhibition ConcentrationMycobacterium tuberculosis
In Vitro/ In vivoMycobacterium tuberculosis H37Rv
Cell LineMIC = 22 ± 4.9 μg/ml or 11.65 ± 2.59 μM
Inhibition ConcentrationIn vitro
Sequence2014
CytotoxicityRBC
In vivo ModelNA
Lethal DoseNo cytotoxicty, No Hemolysis
Immune ResponceNone
Mechanism of ActionNA
TargetNA
Combination TherapyCell wall disruption
Other activitiesCell wall
PMIDNone
Year of PublicationAnti-bacterial (E. coli, S. aureus)
Tertiary Structure
(Technique)
Not Predicted),
Primary information
ID antitb_1194,
Name25019413
N-Terminal modificationPin2 [17]
C-Terminal ModificationFWGLKGLKGPGKFSKKL
Chemical ModificationFree
Linear/CyclicFree
LengthNone
ChiralityLinear
Nature17
SourceL
OriginCationic
SpeciesSynthetic
StrainShort variant of Pin4
Inhibition ConcentrationMycobacterium tuberculosis
In Vitro/ In vivoMycobacterium tuberculosis muti-drug resistant strain (MDR) clinical isolate
Cell LineMIC = 28.0 ± 9.8 μg/ml or 14.85 ± 5.2 μM
Inhibition ConcentrationIn vitro
Sequence2014
CytotoxicityRBC
In vivo ModelNA
Lethal DoseNo cytotoxicty, No Hemolysis
Immune ResponceNone
Mechanism of ActionNA
TargetNA
Combination TherapyCell wall disruption
Other activitiesCell wall
PMIDNone
Year of PublicationAnti-bacterial (E. coli, S. aureus)
Tertiary Structure
(Technique)
Not Predicted),